| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 28 May 2026 | 27 Mar 2026 |
| Procter & Gamble Hygiene And Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 inter alia to consider and approve Audited Financial Statements for the quarter and Financial Year ending on March 31 2026 and recommendation of Final Dividend if any. Financial Results for the financial year ended March 31, 2026 (As Per BSE Announcement Dated On : 28.05.2026) | ||
| Board Meeting | 30 Jan 2026 | 26 Dec 2025 |
| Procter & Gamble Hygiene And Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2026 ,inter alia, to consider and approve Unaudited Financial Results for the quarter ended December 31, 2025. Procter & Gamble Hygiene And Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2026 ,inter alia, to consider and approve The Company has submitted an update on Board Meeting scheduled to be held on January 30, 2026. (As per BSE announcement dated on : 21.01.2026) Dear Sir, Please find enclosed the Financial Results for the quarter ended December 31, 2025. (As per BSE announcement dated on : 30.01.2026) | ||
| Board Meeting | 6 Nov 2025 | 29 Sep 2025 |
| Procter & Gamble Hygiene And Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2025 inter alia to consider and approve Intimation of Board Meeting scheduled to be held on November 6 2025 Purpose of the meeting has been revised (As Per BSE Announcement Dated On : 15.10.2025) Dear Sir, Please find attached Outcome of Board Meeting held on November 6, 2025 (As per BSE Announcement dated on: 06.11.2025) | ||
| Board Meeting | 30 Jul 2025 | 27 Jun 2025 |
| Procter & Gamble Hygiene And Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2025 inter alia to consider and approve unaudited financial results for the quarter ended June 302025 Dear Sir, Please find enclosed unaudited results for the quarter ended June 30, 2025 along with limited review report issued by statutory auditors of the Company. (As Per BSE Announcement Dated on :30.07.2025) | ||
Revenue from operations showed a marginal increase during the quarter, rising to ₹1,261.90 crore, compared with ₹1,247.63 crore in the corresponding period last year
The company, which follows the July-June financial year, declared a profit after tax of ₹210.69 Crore in the same quarter of the previous year.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
